Citius Pharmaceuticals, Inc. (CTXR) has 12 open-market insider trades by 2 insiders since 2016. The most active filer is Leonard L. Mazur, Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Leonard L. Mazur | Chairman | — | 8 | $21.4M | 2019-09-27 |
| Myron Z. Holubiak | CEOPres | — | 4 | $3.4M | 2019-09-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Leonard L. Mazur | Chairman | Buy | $2.0M | 2019-09-27 |
| Myron Z. Holubiak | CEO & President | Buy | $1.0M | 2019-09-27 |
| Myron Z. Holubiak | CEO & President | Buy | $401K | 2019-04-03 |
| Leonard L. Mazur | Chairman | Buy | $3.6M | 2019-04-03 |
| Myron Z. Holubiak | CEO & President | Buy | $2.0M | 2018-08-13 |
| Leonard L. Mazur | Chairman | Buy | $8.0M |
Companies that share insiders with CTXR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-08-13 |
| Leonard L. Mazur | Chairman | Buy | $1.0M | 2018-03-29 |
| Myron Z. Holubiak | President | Buy | $9K | 2018-03-28 |
| Leonard L. Mazur | Chairman | Buy | $2.0M | 2017-12-19 |
| Leonard L. Mazur | Chairman & 10% | Buy | $29K | 2017-08-24 |
| Leonard L. Mazur | Chairman | Buy | $1.7M | 2017-08-08 |
| Leonard L. Mazur | Director | Buy | $3.0M | 2016-03-30 |